Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Janssen "Homemade" Duragesic Promotion Prompts Corrective Letter

Executive Summary

Janssen has sent a corrective letter to 85 physicians in Georgia who received a "homemade" promotion for the transdermal fentanyl product Duragesic.

You may also be interested in...

Roche Tamiflu Ad Letter Continues FDA Scrutiny Of New Flu Drugs

Roche's claim that Tamiflu "reduces the duration of the flu" overstates the efficacy of the drug, FDA maintained in an April 14 letter to Roche.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts